Dr Emily McDonald et Dr Todd Lee.

Dr. Emily McDonald and Dr.Todd Lee have launched a study on the use of fluvoxamine against COVID-19 at the MUHC. Fluvoxamine is originally an antidepressant with anti-inflammatory properties.

"Drug repurposing allows new treatments to be tested faster than new drug development," says Dr. Lee, co-principal investigator. “Based on the promising results of the previous clinical trial, we have high hopes that this drug may prevent hospitalization and reduce the strain on the healthcare system." - Dr. Todd Lee

For more information: